(Press-News.org) McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks for some women later in life.
A new study found that variations in the brain’s insulin receptor network affect how women respond to early-life adversity. This effect has a lesser impact in men, suggesting there is a sex-specific process at play.
The findings, published in Communications Biology (Nature Portfolio), point to the brain’s insulin receptor network as a promising avenue for earlier detection and future prevention strategies for metabolic syndrome, a major driver of cardiovascular disease that affects about one in five Canadian adults.
“We know that women who face childhood adversity are at higher risk for metabolic disease, and this study helps identify who is most susceptible,” said senior author Dr. Patricia Pelufo Silveira, professor of psychiatry at McGill and researcher at the Douglas Research Centre.
Why some women are at higher risk
Metabolic syndrome is a mix of factors, such as high blood pressure, high blood sugar, elevated triglycerides, elevated unhealthy cholesterol and excess abdominal fat that raise the risk of diabetes and cardiovascular diseases.
Analyzing data from more than 32,000 adults, the researchers found that among women who experienced early adversity, only those with a particular pattern of brain-insulin function showed increased abdominal fat and higher metabolic syndrome risk.
Everyone has a brain-insulin function that varies from person to person and appears to be a built-in feature of the brain, rather than something shaped by stress, the researchers note.
“We’re not just talking about severe trauma. Common stresses such as being born with low birth weight, family conflict and physical or emotional neglect also matter,” said first author Angela Marcela Jaramillo-Ospina, a postdoctoral fellow at McGill.
“If we can identify biological sensitivity early, we can intervene before these experiences translate into disease later in life,” she said.
Measuring insulin in the brain
Insulin, well known for regulating blood sugar, also plays a major role in cognition and behaviour. Since insulin can’t be easily measured directly in the brain, the researchers developed a method that uses DNA to find an estimate.
The method was validated by Jaramillo-Ospina in earlier research, which found that children with a similar brain-insulin receptor function and early stress were more likely to crave foods high in sugar and fat, which can set the stage for later metabolic problems.
What’s still unclear is how the brain–insulin pathway regulates metabolic risk and why only some women are sensitive to it. The team plans to trace these signals in future research.
About the study
“Brain insulin receptor gene network shapes risk for metabolic disease after early-life stress in women” by Angela Marcela Jaramillo-Ospina and Patricia Pelufo Silveira et al., was published in Communications Biology.
This research was supported by the Canadian Institutes of Health Research, the JPB Foundation, McGill’s Healthy Brains, Healthy Lives initiative and the McGill-Douglas Max Planck Institute of Psychiatry International Collaborative Initiative in Adversity and Mental Health.
END
Brain discovery opens door to earlier detection of metabolic syndrome in women
Researchers develop a method to measure insulin function in the brain and find patterns that can identify women at higher risk
2025-12-09
ELSE PRESS RELEASES FROM THIS DATE:
SwRI-led study provides insight into oscillations in solar flares
2025-12-09
SAN ANTONIO — December 9, 2025 — A new study led by Southwest Research Institute (SwRI) links quasi-periodic pulsations (QPPs) in solar flares to dynamic oscillations in magnetic reconnection, a phenomenon that can drive space weather and affect technology on Earth. This research could help refine traditional solar flare models and provide new insights into the mechanisms driving them.
Magnetic reconnection occurs when magnetic field lines in plasma break and reconnect, releasing immense energy into the surrounding atmosphere ...
Announcing the third cohort of the Hevolution/AFAR new investigator awards in aging biology and geroscience research
2025-12-09
New York, NY —The American Federation for Aging Research (AFAR) and Hevolution Foundation are pleased to announce the third cohort of the Hevolution/AFAR New Investigator Awardees in Aging Biology and Geroscience Research. This grant program enables junior investigators with labs in the US and Canada, and with at least three years of independent research, to advance research projects in basic biology of aging, as well as geroscience projects that translate advances in basic research on aging biology from the laboratory to the clinic, paving ...
GeoFlame VISION: Using AI and satellite imagery to predict future wildfire risk
2025-12-09
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 9, 2025
GeoFlame VISION: Using AI and Satellite Imagery to Predict Future Wildfire Risk
A new computer model produces a dynamic wildfire risk map,
starting with the state of California
Washington, D.C., December 9, 2025 – Wildfires pose a significant threat across the southwestern United States, due to the region’s unique topography and weather conditions. Accurately identifying locations at the highest risk of a severe wildfire is critical ...
Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease
2025-12-09
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 9, 2025
Nationwide Study Suggests that Water Treatment Methods May Impact the Risk of Legionnaires’ Disease
Higher rates of disease are seen in zip codes served by water treatment plants that use chlorine as the primary disinfectant
Washington, D.C., December 9, 2025 – Preliminary results of a nationwide study suggest that the disinfectant used to treat water before it is distributed through pipes may impact the incidence of Legionnaire’s disease in certain parts of the country. The findings will be presented Dec. 9 at the annual meeting of the Society for Risk Analysis in Washington, D.C.
Waterborne ...
Oyster larvae on drugs move slowly and are stressed
2025-12-09
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 9, 2025
Oyster Larvae on Drugs Move Slowly and Are Stressed
Study finds that exposure to addictive drugs like fentanyl and ketamine affect the behavior and survival rates of oyster larvae
Washington, D.C., December 9, 2025 – The discharge and prevalence of psychoactive drugs in surface waters has raised concerns about potential risks to ecosystems and public health. Yet there is limited information on the ecotoxicity of these compounds in marine environments and aquaculture.
A study presented on Dec. 9 at the annual meeting of the Society for Risk Analysis in ...
Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds
2025-12-09
PULLMAN, Wash. -- Washington State University researchers have discovered how a neural circuit – or a connection between two brain regions – drives relapse after opioid use, a finding that could lead to more effective treatments for opioid use disorders.
In a study published in the Journal of Neuroscience, researchers in the Department of Integrative Physiology and Neuroscience at WSU’s College of Veterinary Medicine used a preclinical model to model opioid use in humans and found that reducing the activity within a specific neuronal ...
Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma
2025-12-09
(ORLANDO, Dec. 9, 2025) Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% more likely to be alive without disease progression compared with those who received standard second-line therapies at a median of nearly 35 months of follow-up, according to the results of a new trial presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.
The ...
Improving treatment for an autoimmune bleeding condition
2025-12-09
PHILADELPHIA – More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening bleeding, were able to maintain safe platelet counts without serious bleeding episodes for at least one year. The results were published today in the New England Journal of Medicine, by researchers from the Perelman School of Medicine at the University of Pennsylvania, and presented by collaborators at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition Orlando, Florida (LBA-2).
ITP is an autoimmune condition where ...
Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery
2025-12-09
(ORLANDO, Dec. 9, 2025) –– When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) or a placebo, patients who received TXA needed significantly fewer blood transfusions and saw no increase in potentially life-threatening blood clots (thrombosis) after 90 days of follow-up, according to research presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.
“Our findings confirm that TXA reduces the need for blood transfusion in patients ...
Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia
2025-12-09
(ORLANDO, Dec. 9, 2025) Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or needing another treatment for their ITP, compared with patients who received a placebo in addition to standard therapy. The study is the first to test a novel drug for ITP early in the disease course and was presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition.
“In patients for whom first-line therapy had stopped working, treatment ...
LAST 30 PRESS RELEASES:
Antimicrobial effects of Syzygium aromaticum and Salvadora persica against common peri-implantitis pathogens in vitro
EVs pose no greater risk to pedestrians than conventional vehicles
Modeling microplastic accumulation under the ocean surface
Pompeii offers insights into ancient Roman building technology
University of Utah engineers give a bionic hand a mind of its own
Transient and long-term risks of common physical activities in people with low back pain
Health care contact days in older adults with metastatic cancer
Brain resilience science reshapes psychiatry from treating illness to building strength
An assessment of the antidepressant potential of deramciclane in two animal tests
Pitt and UPMC study finds epigenetic signature of pediatric traumatic brain injury, paves way for precision recovery tools
Brain discovery opens door to earlier detection of metabolic syndrome in women
SwRI-led study provides insight into oscillations in solar flares
Announcing the third cohort of the Hevolution/AFAR new investigator awards in aging biology and geroscience research
GeoFlame VISION: Using AI and satellite imagery to predict future wildfire risk
Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease
Oyster larvae on drugs move slowly and are stressed
Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds
Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma
Improving treatment for an autoimmune bleeding condition
Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery
Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia
Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL
Online tracking and privacy on hospital websites
A freely available tool to document wartime destruction
Residential solar panels can raise electricity rates
Scientists use synthetic platelets as ‘Trojan horse’ drug-delivery system
Cooperative Intermolecular Interactions Regulate Supramolecular Polymer Assembly
Korea University researchers develop ultrasensitive method to detect low-frequency cancer mutations
First patient enrolled in GOG-3133/ FRAmework-01 phase 3 study evaluating sofetabart mipitecan (LY4170156), a novel ADC targeting folate receptor alpha (FRα), in recurrent ovarian cancer
Two Hebrew University researchers win prestigious ERC consolidator grants
[Press-News.org] Brain discovery opens door to earlier detection of metabolic syndrome in womenResearchers develop a method to measure insulin function in the brain and find patterns that can identify women at higher risk